This is consistent with the data obtained by Semprucci et al. (2016), in which ET-1 stimulation amplified the RhoA/C expression, which was prevented by the addition of macitentan in the epithelial ovarian cancer (EOC) cell line HEY [25]. The gene discussed is EDN1; the disease is ovarian carcinoma.